Raymond James raised the firm’s price target on Boston Scientific (BSX) to $119 from $101 and keeps a Strong Buy rating on the shares. Boston Scientific is still one of the most dynamic companies in ...
In honor of all the news stories that would have made the papers, back in the bad old days when we actually bought and read a full newspaper, here are six recent retirement news items that didn't make ...
Equities researchers at Raymond James reduced their FY2024 earnings estimates for shares of Canadian National Railway in a research report issued on Monday, January 27th. Raymond James analyst S.
Monster Jam invades Tampa this weekend, where the world's biggest, baddest monster trucks take over Raymond James Stadium. One driver wants to inspire young girls to get interested into her sport.
First Merchants Bank's profits rose by 52% in the fourth quarter, though its net income dipped for the year. The Muncie-based bank, which has had a large footprint in Northwest Indiana since acquiring ...
Financial Officer Rick Korf reported to the board the district was a plus $400,000 in December, and the tentative 2024 numbers show a profit of $1.3 million. The Yuma Clinic was up $380,000 in 2024, ...